BAM
CRSP icon

Blueshift Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Blueshift Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,506
Closed -$305K – 957
2021
Q1 		$305K Buy
2,506
+958
+62% +$117K 0.03% 631
2020
Q4 		$237K Buy
+1,548
New +$237K 0.03% 579